Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration.

@article{MeierKriesche2003MycophenolateMV,
  title={Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration.},
  author={Herwig-Ulf Meier-Kriesche and Bettina J Steffen and Alan Hochberg and R. Douglas Gordon and Michael N. Liebman and Jonathan A. Morris and Bruce Kaplan},
  journal={Transplantation},
  year={2003},
  volume={75 8},
  pages={1341-6}
}
BACKGROUND To evaluate the association of long-term continuous mycophenolate mofetil (MMF) versus azathioprine (AZA) therapy and renal allograft function, as measured by the slope of reciprocal creatinine, we analyzed 49,666 primary renal allograft recipients reported to the United States Renal Data System between October 31, 1988 and June 30, 1998… CONTINUE READING